Roche 2022 q1Roche productRoche presentationRoche investor eventsRoche Holding AGRoche

For investors - Roche

文章推薦指數： 80 %
投票人數：10人

Our investor relations team ; Bruno Eschli. Head of Investor Relations. +41 61 687 5284 ; Sabine Borngräber. IR Officer. +41 61 688 8027 ; Birgit Masjost. IR ... MediaInvestorsCareersAboutRocheAboutRocheStrategyBusinessSustainabilityLeadershipGovernanceHistorySolutionsSolutionsFocusareasPharmasolutionsDiagnosticssolutionsPipelineInnovationInnovationTeam&structureInnovationprocessEthicalstandardsPartneringStoriesInvestorcontactsRocheinvestorrelationsgroupheadquartersF.Hoffmann-LaRocheLtd.InvestorRelationsCH-4070BaselSwitzerlandViewonGoogleMapsForallgeneralenquiriespleasecalltheRocheswitchboardon+41616881111ForIRrequestsuse+41616888880+41616910014EmailIRTeamOurinvestorrelationsteamBrunoEschliHeadofInvestorRelations+41616875284SabineBorngräberIROfficer+41616888027BirgitMasjostIROfficer+41616884814GerardTobinIROfficer+41616872942BeatriceHauCoordination+41616889274MelanieWolfCoordination+41616878259EvaLosertCoordination+41616880284RocheinvestorrelationsgroupNorthAmericaRocheHoldings,Inc.Genentech,Inc.InvestorRelationsNorthAmerica1DNAWaySouthSanFrancisco,CA94080USAViewonGoogleMapsForallgeneralenquiriespleasecalltheGenentechswitchboardon+16502251000ForIRrequestsuse+16502255566+16502258326EmailIRTeamYourcontactpersonLorenKalmInvestorRelationsOfficer+1650-225-3217AdverseeventreportingPleasenotethattheprovidedinvestorcontactsonthissitearenottobeusedtoreportadverseeventsortoaskanyquestionsregardingmedicalproducts.Reportingside-effectsrelatedtoourproductsshouldbesenttoyourRochelocalsafetycontact.Forcountry-specificcontactdetailsPleasevisitthissite.PatientsarebeingaskedtoprimarilycontacttheirpersonalphysicianDiscovermore

請為這篇文章評分？

延伸文章資訊